Argatroban for elective percutaneous coronary intervention: The ARG-E04 multi-center study

International Journal of Cardiology

Volumn 148, Issue 2, 2011, Pages 214-219

  Rossig L ^a   Genth Zotz, S ^b   Rau, M ^c   Heyndrickx, G R ^d   Schneider, T ^e   Gulba, D C L ^f   Desaga, M ^g   Buerke, M ^h   Harder, S ^a   Zeiher, A M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

^d CARDIOVASCULAR CENTER   (Belgium)

^e UNIVERSITY OF COLOGNE   (Germany)

^f Krankenhaus Duren gem GmbH   (Germany)

^g Amper Kliniken AG   (Germany)

^h MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Anticoagulation; Direct antithrombin agents; Elective PCI; Heparin

Indexed keywords

ACETYLSALICYLIC ACID; ARGATROBAN; CLOPIDOGREL; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PIPECOLIC ACIDS; THROMBOSIS;

EID: 78049426047     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.02.044     Document Type: Article

References (17)

1. B.E. Lewis, D.E. Wallis, and S.D. Berkowitz Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia Circ 103 2001 1838 1843 (Pubitemid 32328395)
2. R.W. Yeh, and I.K. Jang Argatroban: update Am Heart J 151 2006 1131 1138 (Pubitemid 43866614)
3. B.E. Lewis, W.H. Matthai Jr., and M. Cohen Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia Catheter Cardiovasc Interv 57 2002 177 184
4. I.K. Jang, B.E. Lewis, and W.H. Matthai Jr. Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study J Thromb Thrombolysis 18 2004 31 37 (Pubitemid 40361646)
5. J.H. Chesebro, G. Knatterud, and R. Roberts Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circ 76 1987 142 154 (Pubitemid 17093202)
6. I. Cruz-Gonzalez, M. Sanchez-Ledesma, and S.J. Baron Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome J Thromb Thrombolysis 25 2008 214 218 (Pubitemid 351583670)
7. M. Di Nisio, S. Middeldorp, and H.R. Buller Direct thrombin inhibitors N Engl J Med 353 2005 1028 1040 (Pubitemid 41262337)
8. F. Feit, M.D. Voeltz, and M.J. Attubato Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial Am J Cardiol 100 2007 1364 1369 (Pubitemid 47576015)
9. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697 (Pubitemid 351221218)
10. A. Kastrati, F.J. Neumann, and J. Mehilli ISAR-REACT 3 Trial Investigators. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 2008 688 696
11. J.M. Walenga, S. Ahmad, and D. Hoppensteadt Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia Thromb Res 105 2002 401 405 (Pubitemid 34621257)
12. P. Eichler, N. Lubenow, and U. Strobel Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin Blood 103 2004 613 616 (Pubitemid 38140095)
13. R.F. Bonvini, V. Verin, and M. Righini Bivalirudin in acute coronary syndromes N Engl J Med 356 2007 1070
14. D. Reddan, L.A. Szczech, and S. O'Shea Anticoagulation in acute cardiac care in patients with chronic kidney disease Am Heart J 145 2003 586 594 (Pubitemid 36403486)
15. S.K. Swan, and M.J. Hursting The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction Pharmacother 20 2000 318 329 (Pubitemid 30140749)
16. S. Chia, E.M. Van Cott, and O.C. Raffel Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation Thrombosis Haemost. 101 3 2009 535 540
17. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150